GlassScriptPhysician profile
Dung T Tran
NPI 1386644342
$8,811.06
in general payments reported to CMS, 2019-2025
50 companies · $1,156 in 2025
The $1,156 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $1,615 · 2021: $1,414 · 2022: $1,270 · 2023: $1,231 · 2024: $1,133 · 2025: $1,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,519.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,618.38 | 2020-2025 | Vraylar, Linzess, Ubrelvy |
| Glaxosmithkline, LLC. | $1,446.04 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $933.55 | 2019-2025 | |
| Lilly USA, LLC | $617.22 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $465.43 | 2020-2025 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $398.84 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.16 | 2019-2023 | Jardiance |
| Allergan, INC. | $364.91 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $327.27 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $236.67 | 2019-2021 | |
| Amgen INC. | $166.53 | 2020-2025 | Repatha, Otezla, Otezla |
| Merck Sharp & Dohme LLC | $164.19 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Biohaven Pharmaceuticals, INC. | $147.23 | 2020-2021 | |
| Ardelyx, INC. | $132.83 | 2025 | Ibsrela |
| Biohaven Pharmaceutical Holding Company LTD. | $128.05 | 2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dung Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.